NASDAQ:ENLV   Enlivex Therapeutics Ltd
The drug Allocetra saves the lives of patients in a severe condition from the virus in Israel.
The end of the Phase 2 trial is about to be published soon.
preventing or treating complications associated with sepsis, COVID-19, bone-marrow transplants and solid tumors.
At the end of 2021, the drug report on patients will be published.
Last chance before takeoff.
Opinion only not a professional recommendation.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.